Concepedia

Pedram Basirjafar

PB

Statistics

Publications

3

Citations

45

H-Index

3

Active since

2022

Affiliations

Rafsanjan University of Medical Sciences(Current)

Kerman University of Medical Sciences

Tabriz University of Medical Sciences

Pedram Basirjafar is an author at Rafsanjan University of Medical Sciences specializing in vaccination, cancer immunology, and cancer immunotherapy.

ORCID

Publications per year

2022–2023

3

Publications

3

Inhibition of apelin/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer

Javad Masoumi, Abdollah Jafarzadeh, Tayyebeh Tavakoli et al. · Advances in Medical Sciences · 2022 · 20 citations

, , +17

Apelin receptor antagonist boosts dendritic cell vaccine efficacy in controlling angiogenic, metastatic and apoptotic-related factors in 4T1 breast tumor-bearing mice

Javad Masoumi, Nahid Zainodini, Pedram Basirjafar et al. · Medical Oncology · 2023 · 13 citations

, , +17

Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model

Raziyeh Zandvakili, Pedram Basirjafar, Javad Masoumi et al. · Advances in Medical Sciences · 2023 · 12 citations

, , +13

1–3 of 3